Neomabs Biothechnologies Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2M

  • Investors
  • 2

Neomabs Biothechnologies General Information

Description

Developer of therapeutic antibodies intended to treat cancer. The company specializes in using ultra-efficient methods of proteomics, immunopeptides, and computational mass spectrometry which provides new immunotherapies directed against new targets, neo-antigens, and acute pediatric leukemia, enabling patients to get treated effectively with immunotherapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3175 Chem de la Côte-Sainte-Catherine
  • Montreal, Quebec H3T 1C5
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3175 Chem de la Côte-Sainte-Catherine
  • Montreal, Quebec H3T 1C5
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neomabs Biothechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 07-Jun-2023 $2M Completed Startup
To view Neomabs Biothechnologies’s complete valuation and funding history, request access »

Neomabs Biothechnologies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eureka Corporate Group PE/Buyout Minority
Seido Capital Venture Capital Minority
To view Neomabs Biothechnologies’s complete investors history, request access »

Neomabs Biothechnologies FAQs

  • When was Neomabs Biothechnologies founded?

    Neomabs Biothechnologies was founded in 2022.

  • Where is Neomabs Biothechnologies headquartered?

    Neomabs Biothechnologies is headquartered in Montreal, Canada.

  • What industry is Neomabs Biothechnologies in?

    Neomabs Biothechnologies’s primary industry is Drug Discovery.

  • Is Neomabs Biothechnologies a private or public company?

    Neomabs Biothechnologies is a Private company.

  • What is Neomabs Biothechnologies’s current revenue?

    The current revenue for Neomabs Biothechnologies is .

  • How much funding has Neomabs Biothechnologies raised over time?

    Neomabs Biothechnologies has raised $2M.

  • Who are Neomabs Biothechnologies’s investors?

    Eureka Corporate Group and Seido Capital have invested in Neomabs Biothechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process